Small Pharma Inc. (CVE:DMT – Get Rating)’s share price traded down 11.1% during trading on Tuesday . The stock traded as low as C$0.08 and last traded at C$0.08. 12,000 shares traded hands during trading, a decline of 95% from the average session volume of 241,725 shares. The stock had previously closed at C$0.09.
Small Pharma Stock Performance
The firm’s 50-day simple moving average is C$0.07 and its 200 day simple moving average is C$0.09. The company has a market cap of C$24.12 million, a P/E ratio of -0.94 and a beta of 1.97.
Small Pharma Company Profile
Small Pharma Inc, a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder.
- Toll Brothers Rises On Results, But The Roof Is In Place
- It’s Time To Try On VF Corporation’s 6% Yield
- PetCo Management Getting it Right? Earnings Beat Says Yes
- Axcelis Stock In Buy Range After Chart Breakout, Strong Guidance
- Kohl’s 10% Yield Comes Into High Fashion
Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with MarketBeat.com's FREE daily email newsletter.